Broadcom has placed 3nm chip orders with TSMC joining the foundry’s N3 and N3E process customers that include Apple, Qualcomm, MediaTek, Nvidia and AMD, according to industry sources.
Regeneron’s and Sanofi’s Dupixent SmPC Updated With Long-term Data Reinforcing Well-established Safety Profile in Adults With Moderate-to-severe Atopic Dermatitis
Long-term safety data from a study of adults with moderate-to-severe atopic dermatitis treated with Dupixent will be added to the Dupixent Summary of Product Characteristics (SmPC) following a positive opinion issued by the European Medicines Agency's Committee for Medicinal Products for Human Use.
